(2)(1)(3)Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience - Kratochwil, C; Giesel, F L; Bruchertseifer, F (Eur J Nucl Med Mol Imaging, 2014)
et al.